ResveratrolanimalAnimal model2001

Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human.

Archives of biochemistry and biophysics

confidence

Key findings

Resveratrol glucuronidation is regio- and stereoselective, forming 3-O- and 4'-O-glucuronides; catalyzed mainly by UGT1A family enzymes.

View source on PubMed (PMID 11556815) ↗

Sample size
Not applicable (in vitro enzymatic study)
Population
Human liver microsomes and recombinant UGT isoforms (in vitro)
Dosing
Not reported
Duration
Not reported
Route
In vitro
Blinding
not_reported
Controls
none
Drug class
polyphenol
Full abstract

Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a polyphenol present in wine, which has been reported to have anti-inflammatory, anti-platelet, and anti-carcinogenic effects. The glucuronidation of this compound and that of the cis-isomer also naturally present, has been investigated in human liver microsomes. Both isomers were actively glucuronidated. The reaction led to the formation of two glucuronides (3-O- and 4'-O-glucuronides), whose structure was characterized by LC-MS and proton NMR. Glucuronidation was regio- and stereoselective. It occurred at a faster rate with the cis-isomer and preferred the 3-position on both isomers. In addition, the glucuronidation of resveratrol was tested using several recombinant UDP-glucuronosyltransferase (UGT) isoforms. The reaction was catalyzed by UGT of the family 1A (UGT1A1, 1A6, 1A7, 1A9, 1A10). The bilirubin conjugating UGT1A1 was mainly involved in the 3-O-glucuronidation of trans-resveratrol, whereas the phenol conjugating UGT1A6 activity was restricted to cis-resveratrol. The UGT1A9 and 1A10 were active toward both isomers. The activity supported by UGT2B7 and UGT2B15 was very low and restricted to cis-resveratrol. UGT1A3, 1A4, 2B4, and 2B11 were unable to form resveratrol glucuronides.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.